Developing innovative formulations of therapeutic peptides to achieve convenient dosage forms is a key focus for our team and we have an excellent track record in this field
People looking to manage their weight and reduce food consumption
Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunstrom E
Disclosures: Caroline Schwarz: Abbvie, Gilead, Gebro, Galapagos: travel support, Abbvie, Gilead: Speaking and Teaching, Gilead: Consultant, Bernadette Becsi: Nothing to Disclose, Stephan Leick: Nothing to Disclose, Stephan Gretel: Nothing to Disclose, Lena Wien: Nothing to Disclose, Enisa Gutic: Nothing to Disclose, Thomas Reiberger: Nothing to Disclose, Hans Haltmayer: Nothing to Disclose, Michael Gschwantler: Nothing to Disclose 513 PROGRESS TOWARDS ACHIEVING HEPATITIS C ELIMINATION IN THE COUNTRY OF GEORGIA, APRIL 2015 MARCH 2024 Tengiz Tsertsvadze 1 Akaki Abutidze 1 Lali Sharvadze 2 Maia Butsashvili 3 Jaba Zarkua 4 Rania Tohme 5 Shaun Shadaker 5 Ekaterine Adamia 6 Tamar Gabunia 7 , 1 Infectious Diseases, AIDS and Cl
